Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands.
Pharmacol 134, 691-699, (2001). Bermack, J. E., & Debonnel, G. View abstract in PubMed
The antidepressant-like effect induced by sigma-1 receptor agonists and neuroactive steroids in mice submitted to the forced swimming test.
J Pharmacol Exp Ther 298, 1269-1279, (2001). Urani, A., Roman, F. J., Phan, V., Su, T. P., & Maurice, T. View abstract in PubMed
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Journal of Neuropathology and Experimental Neurology Vol. 60, No. 8, August, 2001 Akihiko Nunomura, MD, PH.D., George Perry, PH.D., Gjumrakch Aliev, MD, PH.D., Keisuke Hirai, PH.D., Atsushi Takeda, MD, PH.D., Elizabeth K. Balraj, MD, Paul K. Jones, PH.D., Hossein Ghanbari, PH.D., Takafumi Wataya, MD, Shun Shimohama, MD, PH.D., Shigeru Chiba, MD, PH.D., Craig S. Atwood,…
Molecular cloning and pharmacological characterization of the rat σ1 receptor.
Biochem Pharmacol 62, 349-355, (2001). Mei, J., & Pasternak, G. W. View abstract in PubMed
Neuroprotective effect of sigma-1 receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production.
Stroke 32, 1613-1620, (2001). Goyagi, T., Goto, S., Bhardwaj, A., Dawson, V. L., Hurn, P. D., & Kirsch, J. R. View abstract in PubMed
Regulating ankyrin dynamics: Roles of sigma-1 receptors.
Proc Natl Acad Sci USA 98, 491-496, (2001). Hayashi, T., & Su, T. P View abstract in PubMed
How cells handle cholesterol.
Science 290, 1721-1726, (2000). Simons, K., & Ikonen, E View abstract in PubMed
Animal models of Alzheimer’s disease and evaluation of anti-dementia drugs.
Pharmacol Ther 88, 93-113, (2000). Yamada, K., & Nabeshima, T. View abstract in PubMed
Involvement of the sigma1 receptor in the cocaine-induced conditioned place preference.
Neuroreport 11, 2885-2888, (2000). Romieu, P., Martin-Fardon, R., & Maurice, T View abstract in PubMed
Effects of sigma receptor agonists on the impairment of spontaneous alternation behavior and decrease of cyclic GMP level induced by nitric oxide synthase inhibitors in mice.
Neuropharmacology 39, 2391-2398, (2000). Mamiya, T., Noda, Y., Noda, A., Hiramatsu, M., Karasawa, K., Kameyama, T., et al. View abstract in PubMed